Business Context and Reporting Period
This Form 8-K Current Report was filed by Diebold Nixdorf, Inc. on April 24, 2018, regarding events occurring at the Company's Annual Meeting of Shareholders held on April 25, 2018. The filing details shareholder approvals, executive compensation amendments, and corporate governance updates.
Key Financial Metrics
This filing is a current report regarding corporate governance and equity plan amendments. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent 10-K or 10-Q filings for financial statements.
Material Changes and Corporate Actions
- Equity Plan Amendment: Shareholders approved amendments to the 2017 Equity and Performance Incentive Plan, authorizing an additional 1,150,000 common shares for issuance. The amendments also adjust the plan to reflect tax law changes from the Tax Cuts and Jobs Act of 2017.
- Executive Employment Agreement: The Compensation Committee amended Dr. Ulrich Näher's employment agreement on April 24, 2018, extending the term to February 28, 2022 (previously expiring February 28, 2019). This coincides with his additional appointment as CEO of the Diebold Nixdorf AG subsidiary.
- Board Elections: Shareholders elected all eleven (11) nominees for director to serve one-year terms.
- Accounting Firm Ratification: Shareholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for 2018.
Shareholder Voting Results
| Proposal | For Votes | Against Votes | Abstain | Result |
|---|---|---|---|---|
| Election of 11 Directors | Varied by nominee (approx. 55.9M - 58.8M) | Varied by nominee (approx. 1.1M - 4.0M) | Varied by nominee (approx. 136K - 154K) | Approved |
| Ratification of KPMG LLP | 65,885,752 | 1,629,019 | 137,828 | Approved |
| Advisory Executive Compensation | 54,169,641 | 5,735,772 | 192,161 | Approved |
| Amendments to 2017 Equity Plan | 50,097,148 | 9,794,631 | 205,795 | Approved |
Outlook, Risks, and Contingencies
The filing does not contain forward-looking guidance, risk factors, or contingency disclosures beyond the standard reference to the definitive proxy statement (Schedule 14A) for further details on the equity plan and executive compensation. The extension of Dr. Näher's employment term indicates management continuity through 2022.
Key Facts for Investor Verification
- Verify the impact of the 1,150,000 share increase in the equity plan on potential future dilution.
- Review the full text of the amended 2017 Plan (Exhibit 10.1) to understand specific adjustments made for the Tax Cuts and Jobs Act of 2017.
- Confirm the terms of Dr. Ulrich Näher's extended employment agreement, particularly regarding compensation and performance metrics through 2022.
- Note that the advisory vote on executive compensation received significant support but also saw approximately 9.6% of votes cast against (5.7M against vs 54.1M for).